Last reviewed · How we verify

NCT06951620

Optimizing Aerobic Fitness in Older Adults

Recruiting now NA Last updated 8 June 2025
What this trial tests

NA trial testing HIIT in Aerobic Capacity in 114 participants. Currently enrolling.

Timeline
17 April 2025
Primary endpoint
15 March 2029
30 June 2029

Quick facts

Lead sponsorUniversity of Vermont Medical Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment114
Start date17 April 2025
Primary completion15 March 2029
Estimated completion30 June 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Vermont Medical Center

Who can join

65 and older, any sex, with Aerobic Capacity or High Intensity Interval Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hospitalization and treatment for cardiovascular disease is one of the main contributors to disability in older adults. Moderate intensity continuous aerobic and resistance training have been the cornerstone of cardiac rehabilitation (CR) for decades to remediate hospital-acquired functional deficits, but some groups receive less or minimal functional benefit from this training. The proposed studies seek to optimize recovery of aerobic fitness and physical function among older cardiac patients using a novel high intensity training regimen with the long-term goal of reducing subsequent disability and improving clinical outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of HIIT

Trials testing the same drug.

Other recruiting trials for Aerobic Capacity

Currently open trials in the same condition.

Other University of Vermont Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06951620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing